{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:26:46Z","timestamp":1790292406831,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00219563"],"award-info":[{"award-number":["RS-2023-00219563"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00430-025-00851-1","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:01:15Z","timestamp":1758265275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic potential of Bacillus sonorensis PMC204 membrane vesicles against drug-resistant Mycobacterium tuberculosis"],"prefix":"10.1007","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5426-4050","authenticated-orcid":false,"given":"Youngkyoung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5932-6633","authenticated-orcid":false,"given":"Hoonhee","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6284-9999","authenticated-orcid":false,"given":"Soyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2516-5616","authenticated-orcid":false,"given":"Dongsic","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-5602","authenticated-orcid":false,"given":"Md Abdur","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4429-1383","authenticated-orcid":false,"given":"Ho-Yeon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"851_CR1","unstructured":"Global tuberculosis report 2023 (2023) [Online]. Available: https:\/\/iris.who.int\/"},{"key":"851_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-022-00145-0","author":"M Tovar","year":"2022","unstructured":"Tovar M, Aleta A, Sanz J, Moreno Y (2022) Modeling the impact of COVID-19 on future tuberculosis burden. Commun Med. https:\/\/doi.org\/10.1038\/s43856-022-00145-0","journal-title":"Commun Med"},{"key":"851_CR3","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.ijid.2021.02.067","volume":"113","author":"S Tiberi","year":"2021","unstructured":"Tiberi S, Vjecha MJ, Zumla A, Galvin J, Migliori GB, Zumla A (2021) Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic. Int J Infect Dis 113:S96\u2013S99. https:\/\/doi.org\/10.1016\/j.ijid.2021.02.067","journal-title":"Int J Infect Dis"},{"key":"851_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/J.TUBE.2020.101917","volume":"121","author":"JA Garrido-Cardenas","year":"2020","unstructured":"Garrido-Cardenas JA, de Lamo-Sevilla C, Cabezas-Fern\u00e1ndez MT, Manzano-Agugliaro F, Mart\u00ednez-Lirola M (2020) Global tuberculosis research and its future prospects. Tuberculosis 121:101917. https:\/\/doi.org\/10.1016\/J.TUBE.2020.101917","journal-title":"Tuberculosis"},{"issue":"7","key":"851_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/resp.13304","volume":"23","author":"C Lange","year":"2018","unstructured":"Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K (2018) Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. Respirology 23(7):656\u2013673. https:\/\/doi.org\/10.1111\/resp.13304","journal-title":"Respirology"},{"issue":"2","key":"851_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/joim.12780","volume":"284","author":"C Lange","year":"2018","unstructured":"Lange C et al (2018) Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. J Intern Med 284(2):163\u2013188. https:\/\/doi.org\/10.1111\/joim.12780","journal-title":"J Intern Med"},{"issue":"7","key":"851_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"PPF Prestinaci","year":"2015","unstructured":"Prestinaci PPF, Pantosti A (2015) Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 109(7):309\u2013318. https:\/\/doi.org\/10.1179\/2047773215Y.0000000030","journal-title":"Pathog Glob Health"},{"key":"851_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30110-5","author":"S Tiberi","year":"2018","unstructured":"Tiberi S et al (2018) Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(18)30110-5","journal-title":"Lancet Infect Dis"},{"key":"851_CR9","unstructured":"Food and Agriculture Organization of the United Nations and World Health Organization (2006) Probiotics in food\u00a0: health and nutritional properties and guidelines for evaluation. Food and Agriculture Organization of the United Nations"},{"key":"851_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10068-023-01378-y","author":"N-K Lee","year":"2023","unstructured":"Lee N-K, Park YS, Kang DK, Paik HD (2023) Paraprobiotics: definition, manufacturing methods, and functionality. Korean Soc Food Sci Technol. https:\/\/doi.org\/10.1007\/s10068-023-01378-y","journal-title":"Korean Soc Food Sci Technol"},{"issue":"1","key":"851_CR11","doi-asserted-by":"publisher","first-page":"1600240","DOI":"10.1002\/mnfr.201600240","volume":"61","author":"B S\u00e1nchez","year":"2017","unstructured":"S\u00e1nchez B, Delgado S, Blanco-M\u00edguez A, Louren\u00e7o A, Gueimonde M, Margolles A (2017) Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res 61(1):1600240. https:\/\/doi.org\/10.1002\/mnfr.201600240","journal-title":"Mol Nutr Food Res"},{"issue":"9","key":"851_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41579-020-0367-2","volume":"18","author":"WE Ruff","year":"2020","unstructured":"Ruff WE, Greiling TM, Kriegel MA (2020) Host\u2013microbiota interactions in immune-mediated diseases. Nat Rev Microbiol 18(9):521\u2013538. https:\/\/doi.org\/10.1038\/s41579-020-0367-2","journal-title":"Nat Rev Microbiol"},{"key":"851_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093211","author":"HY Li","year":"2021","unstructured":"Li HY et al (2021) Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: a narrative review. Nutrients. https:\/\/doi.org\/10.3390\/nu13093211","journal-title":"Nutrients"},{"issue":"6","key":"851_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.aller.2020.04.005","volume":"48","author":"M Eslami","year":"2020","unstructured":"Eslami M, Bahar A, Keikha M, Karbalaei M, Kobyliak NM, Yousefi B (2020) Probiotics function and modulation of the immune system in allergic diseases. Allergol Immunopathol (Madr) 48(6):771\u2013788. https:\/\/doi.org\/10.1016\/j.aller.2020.04.005","journal-title":"Allergol Immunopathol (Madr)"},{"key":"851_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101431","author":"R Arrigoni","year":"2022","unstructured":"Arrigoni R, Ballini A, Topi S, Bottalico L, Jirillo E, Santacroce L (2022) Antibiotic resistance to Mycobacterium tuberculosis and potential use of natural and biological products as alternative anti-mycobacterial agents. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics11101431","journal-title":"Antibiotics"},{"key":"851_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00998-9","author":"K Ratiner","year":"2023","unstructured":"Ratiner K, Ciocan D, Abdeen SK, Elinav E (2023) Utilization of the microbiome in personalized medicine. Nat Rev Microbiol. https:\/\/doi.org\/10.1038\/s41579-023-00998-9","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"851_CR17","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1128\/aac.47.12.3682-3687.2003","volume":"47","author":"C Changsen","year":"2003","unstructured":"Changsen C, Franzblau SG, Palittapongarnpim P (2003) Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter. Antimicrob Agents Chemother 47(12):3682\u20133687. https:\/\/doi.org\/10.1128\/aac.47.12.3682-3687.2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"851_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/nar\/28.1.33","volume":"28","author":"RL Tatusov","year":"2000","unstructured":"Tatusov RL, Galperin MY, Natale DA, Koonin EV (2000) The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Res 28(1):33\u201336","journal-title":"Nucleic Acids Res"},{"key":"851_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40104-020-00532-4","author":"R Hu","year":"2021","unstructured":"Hu R et al (2021) Lactobacillus reuteri-derived extracellular vesicles maintain intestinal immune homeostasis against lipopolysaccharide-induced inflammatory responses in broilers. J Anim Sci Biotechnol. https:\/\/doi.org\/10.1186\/s40104-020-00532-4","journal-title":"J Anim Sci Biotechnol"},{"key":"851_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-020-01953-x","author":"R Hu","year":"2020","unstructured":"Hu R et al (2020) Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages. BMC Microbiol. https:\/\/doi.org\/10.1186\/s12866-020-01953-x","journal-title":"BMC Microbiol"},{"key":"851_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-0716-1186-9_11","volume-title":"Proteomic profiling: methods and protocols","author":"D Choi","year":"2021","unstructured":"Choi D, Rak J, Gho YS (2021) Isolation of extracellular vesicles for proteomic profiling. In: Posch A (ed) Proteomic profiling: methods and protocols. Springer, US, New York, NY, pp 193\u2013206. https:\/\/doi.org\/10.1007\/978-1-0716-1186-9_11"},{"issue":"11","key":"851_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112842","volume":"13","author":"S-J Lee","year":"2021","unstructured":"Lee S-J et al (2021) Identification of nucleolin as a novel AEG-1-interacting protein in breast cancer via interactome profiling. Cancers (Basel) 13(11):2842. https:\/\/doi.org\/10.3390\/cancers13112842","journal-title":"Cancers (Basel)"},{"issue":"3","key":"851_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jech-2021-217529","volume":"76","author":"AJ Zimmer","year":"2022","unstructured":"Zimmer AJ et al (2022) Tuberculosis in times of COVID-19. J Epidemiol Community Health 76(3):310\u2013316. https:\/\/doi.org\/10.1136\/jech-2021-217529","journal-title":"J Epidemiol Community Health"},{"key":"851_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m216","author":"A Lee","year":"2020","unstructured":"Lee A, Xie YL, Barry CE, Chen RY (2020) Current and future treatments for tuberculosis. BMJ. https:\/\/doi.org\/10.1136\/bmj.m216","journal-title":"BMJ"},{"key":"851_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065202","author":"KA Jellinger","year":"2023","unstructured":"Jellinger KA, Bustin S, Alsayed SSR, Gunosewoyo H (2023) Tuberculosis: pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24065202","journal-title":"Int J Mol Sci"},{"key":"851_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065202","author":"SSR Alsayed","year":"2023","unstructured":"Alsayed SSR, Gunosewoyo H (2023) Tuberculosis: pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24065202","journal-title":"Int J Mol Sci"},{"key":"851_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9122562","author":"CM Bento","year":"2021","unstructured":"Bento CM, Gomes MS, Silva T (2021) Evolution of antibacterial drug screening methods: current prospects for mycobacteria. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms9122562","journal-title":"Microorganisms"},{"key":"851_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2020.101574","volume":"74","author":"JL Khawbung","year":"2021","unstructured":"Khawbung JL, Nath D, Chakraborty S (2021) Drug resistant Tuberculosis: a review. Comp Immunol Microbiol Infect Dis 74:101574. https:\/\/doi.org\/10.1016\/j.cimid.2020.101574","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"851_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.04.026","author":"DT Hoagland","year":"2016","unstructured":"Hoagland DT, Liu J, Lee RB, Lee RE (2016) New agents for the treatment of drug-resistant Mycobacterium tuberculosis. Adv Drug Deliv Rev. https:\/\/doi.org\/10.1016\/j.addr.2016.04.026","journal-title":"Adv Drug Deliv Rev"},{"key":"851_CR30","doi-asserted-by":"publisher","unstructured":"Butnaru T, Mihaltan FD, Constantin AA (2023) Isoniazid-resistant tuberculosis\u2014a series of clinical cases. https:\/\/doi.org\/10.20944\/preprints202309.1918.v1","DOI":"10.20944\/preprints202309.1918.v1"},{"key":"851_CR31","doi-asserted-by":"publisher","unstructured":"G. E. Walton, J. Villena, K. R. Martin, Y. Liu, J. Wang, and C. Wu, \u201cMicrobiota and Tuberculosis: A Potential Role of Probiotics, and Postbiotics,\u201d Frontiers in Nutrition | www.frontiersin.org, vol. 1, p. 626254, 2021, https:\/\/doi.org\/10.3389\/fnut.2021.626254.","DOI":"10.3389\/fnut.2021.626254"},{"key":"851_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.626254","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang J, Wu C (2021) Microbiota and tuberculosis: a potential role of probiotics, and postbiotics. Front Nutr. https:\/\/doi.org\/10.3389\/fnut.2021.626254","journal-title":"Front Nutr"},{"key":"851_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-021-11140-1","author":"Y Cao","year":"2021","unstructured":"Cao Y, Lin H (2021) Characterization and function of membrane vesicles in gram-positive bacteria. Appl Microbiol Biotechnol. https:\/\/doi.org\/10.1007\/s00253-021-11140-1","journal-title":"Appl Microbiol Biotechnol"},{"key":"851_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5633403","author":"H Zhang","year":"2022","unstructured":"Zhang H et al (2022) Next-generation probiotics: microflora intervention to human diseases. BioMed Res Int. https:\/\/doi.org\/10.1155\/2022\/5633403","journal-title":"BioMed Res Int"},{"issue":"5","key":"851_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.chom.2012.03.008","volume":"11","author":"JJ Kim","year":"2012","unstructured":"Kim JJ et al (2012) Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action. \u00a9 2012 Elsevier Inc. Cell Host Microbe 11(5):457\u2013468. https:\/\/doi.org\/10.1016\/j.chom.2012.03.008","journal-title":"Cell Host Microbe"},{"key":"851_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101274","author":"X Gonzalo","year":"2022","unstructured":"Gonzalo X, Bielecka MK, Tezera L, Elkington P, Drobniewski F (2022) Anti-tuberculosis activity of three carbapenems, clofazimine and nitazoxanide using a novel ex vivo phenotypic drug susceptibility model of human tuberculosis. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics11101274","journal-title":"Antibiotics"},{"key":"851_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.658637","author":"W Zhou","year":"2021","unstructured":"Zhou W et al (2021) Screening of compounds for anti-tuberculosis activity, and in vitro and in vivo evaluation of potential candidates. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.658637","journal-title":"Front Microbiol"},{"key":"851_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.02108","author":"E Lesne","year":"2020","unstructured":"Lesne E et al (2020) Acellular pertussis vaccines induce anti-pertactin bactericidal antibodies which drives the emergence of pertactin-negative strains. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.02108","journal-title":"Front Microbiol"},{"issue":"1","key":"851_CR39","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1186\/s12951-024-02875-w","volume":"22","author":"Y Liu","year":"2024","unstructured":"Liu Y et al (2024) Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy. J Nanobiotechnology 22(1):608. https:\/\/doi.org\/10.1186\/s12951-024-02875-w","journal-title":"J Nanobiotechnology"},{"key":"851_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2018.1536598","author":"S Paik","year":"2019","unstructured":"Paik S, Kim JK, Chung C, Jo EK (2019) Autophagy: a new strategy for host-directed therapy of tuberculosis. Virulence. https:\/\/doi.org\/10.1080\/21505594.2018.1536598","journal-title":"Virulence"},{"key":"851_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.172","author":"IA Hajam","year":"2017","unstructured":"Hajam IA, Dar PA, Shahnawaz I, Jaume JC, Lee JH (2017) Bacterial flagellin-a potent immunomodulatory agent. Exp Mol Med. https:\/\/doi.org\/10.1038\/emm.2017.172","journal-title":"Exp Mol Med"},{"key":"851_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2185031","author":"M Vijay-Kumar","year":"2023","unstructured":"Vijay-Kumar M et al (2023) Bacterial flagellin is a dominant, stable innate immune activator in the gastrointestinal contents of mice and rats. Gut Microbes. https:\/\/doi.org\/10.1080\/19490976.2023.2185031","journal-title":"Gut Microbes"},{"key":"851_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-10146-y","author":"H Afzal","year":"2025","unstructured":"Afzal H, Murtaza A, Cheng LT (2025) Structural engineering of flagellin as vaccine adjuvant: quest for the minimal domain of flagellin for TLR5 activation. Mol Biol Rep. https:\/\/doi.org\/10.1007\/s11033-024-10146-y","journal-title":"Mol Biol Rep"},{"key":"851_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1046472","author":"MZ Alam","year":"2023","unstructured":"Alam MZ, Maslanka JR, Abt MC (2023) Immunological consequences of microbiome-based therapeutics. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1046472","journal-title":"Front Immunol"},{"key":"851_CR45","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018481","author":"V Deretic","year":"2014","unstructured":"Deretic V (2014) Autophagy in tuberculosis. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a018481","journal-title":"Cold Spring Harb Perspect Med"},{"key":"851_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37120-6","author":"SN Dean","year":"2019","unstructured":"Dean SN, Leary DH, Sullivan CJ, Oh E, Walper SA (2019) Isolation and characterization of Lactobacillus-derived membrane vesicles. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-018-37120-6","journal-title":"Sci Rep"},{"issue":"4","key":"851_CR47","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mas.21420","volume":"34","author":"D-S Choi","year":"2015","unstructured":"Choi D-S, Kim D-K, Kim Y-K, Gho YS (2015) Proteomics of extracellular vesicles: exosomes and ectosomes. Mass Spectrom Rev 34(4):474\u2013490. https:\/\/doi.org\/10.1002\/mas.21420","journal-title":"Mass Spectrom Rev"},{"issue":"1","key":"851_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ (2019) Exosomes. Annu Rev Biochem 88(1):487\u2013514. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111902","journal-title":"Annu Rev Biochem"},{"key":"851_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1165202","author":"P L\u00f3pez","year":"2023","unstructured":"L\u00f3pez P, Russo P, Magni C, P\u00e9rez Mart\u00ednez G (2023) Bacterial extracellular vesicles and associated functional proteins in fermented dairy products with Lacticaseibacillus paracasei. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2023.1165202","journal-title":"Front Microbiol"},{"key":"851_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.172","author":"IA Hajam","year":"2017","unstructured":"Hajam IA, Dar PA, Shahnawaz I, Jaume JC, Lee JH (2017) Bacterial flagellin\u2014a potent immunomodulatory agent. Exp Mol Med. https:\/\/doi.org\/10.1038\/emm.2017.172","journal-title":"Exp Mol Med"},{"key":"851_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.01.005","author":"V Le Moigne","year":"2008","unstructured":"Le Moigne V, Robreau G, Mahana W (2008) Flagellin as a good carrier and potent adjuvant for Th1 response: study of mice immune response to the p27 (Rv2108) Mycobacterium tuberculosis antigen. Mol Immunol. https:\/\/doi.org\/10.1016\/j.molimm.2008.01.005","journal-title":"Mol Immunol"},{"key":"851_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep18379","author":"Y Lu","year":"2016","unstructured":"Lu Y, Swartz JR (2016) Functional properties of flagellin as a stimulator of innate immunity. Sci Rep. https:\/\/doi.org\/10.1038\/srep18379","journal-title":"Sci Rep"},{"key":"851_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2009.9","author":"M Vijay-Kumar","year":"2009","unstructured":"Vijay-Kumar M, Gewirtz AT (2009) Flagellin: key target of mucosal innate immunity. Mucosal Immunol. https:\/\/doi.org\/10.1038\/mi.2009.9","journal-title":"Mucosal Immunol"},{"key":"851_CR54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1305316110","author":"SL Lage","year":"2013","unstructured":"Lage SL et al (2013) Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage responses. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.1305316110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"851_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12413-z","author":"MA Rahim","year":"2022","unstructured":"Rahim MA et al (2022) In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-12413-z","journal-title":"Sci Rep"},{"key":"851_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02334","author":"X Ye","year":"2018","unstructured":"Ye X, Zhou XJ, Zhang H (2018) Exploring the role of autophagy-related gene 5 (ATG5ATG5) yields important insights into autophagy in autoimmune\/autoinflammatory diseases. Front Media SA. https:\/\/doi.org\/10.3389\/fimmu.2018.02334","journal-title":"Front Media S.A."},{"key":"851_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-007-0078-z","author":"EA Miao","year":"2007","unstructured":"Miao EA, Andersen-Nissen E, Warren SE, Aderem A (2007) TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin Immunopathol. https:\/\/doi.org\/10.1007\/s00281-007-0078-z","journal-title":"Semin Immunopathol"},{"key":"851_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/srep40878","author":"WS Song","year":"2017","unstructured":"Song WS, Jeon YJ, Namgung B, Hong M, Yoon SI (2017) A conserved TLR5 binding and activation hot spot on flagellin. Sci Rep. https:\/\/doi.org\/10.1038\/srep40878","journal-title":"Sci Rep"},{"key":"851_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17935-5","author":"A Tahoun","year":"2017","unstructured":"Tahoun A et al (2017) Host species adaptation of TLR5 signalling and flagellin recognition. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-17935-5","journal-title":"Sci Rep"},{"key":"851_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10080908","author":"MKN Mazlan","year":"2021","unstructured":"Mazlan MKN et al (2021) Antituberculosis targeted drug delivery as a potential future treatment approach. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics10080908","journal-title":"Antibiotics"},{"key":"851_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.782495","author":"HA Parker","year":"2021","unstructured":"Parker HA, Forrester L, Kaldor CD, Dickerhof N, Hampton MB (2021) Antimicrobial activity of neutrophils against mycobacteria. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.782495","journal-title":"Front Immunol"},{"issue":"10","key":"851_CR62","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1016\/j.apsb.2021.04.019","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J et al (2021) Salmonella flagella confer anti-tumor immunological effect via activating flagellin\/TLR5 signalling within tumor microenvironment. Acta Pharm Sin B 11(10):3165\u20133177. https:\/\/doi.org\/10.1016\/j.apsb.2021.04.019","journal-title":"Acta Pharm Sin B"},{"key":"851_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58020188","author":"J Espinosa-Pereiro","year":"2022","unstructured":"Espinosa-Pereiro J, S\u00e1nchez-Montalv\u00e1 A, Aznar ML, Espiau M (2022) MDR tuberculosis treatment. Medicina. https:\/\/doi.org\/10.3390\/medicina58020188","journal-title":"Medicina"},{"key":"851_CR64","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00141-20","author":"SN Goossens","year":"2020","unstructured":"Goossens SN, Sampson SL, Rie AV (2020) Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/cmr.00141-20","journal-title":"Clin Microbiol Rev"},{"key":"851_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13213-024-01773-8","author":"H Tajdozian","year":"2024","unstructured":"Tajdozian H et al (2024) Efficacy of lyophilized Lactobacillus sakei as a potential candidate for preventing carbapenem-resistant Klebsiella infection. Ann Microbiol. https:\/\/doi.org\/10.1186\/s13213-024-01773-8","journal-title":"Ann Microbiol"},{"issue":"5","key":"851_CR66","doi-asserted-by":"publisher","first-page":"17057","DOI":"10.1038\/nmicrobiol.2017.57","volume":"2","author":"PW O\u2019Toole","year":"2017","unstructured":"O\u2019Toole PW, Marchesi JR, Hill C (2017) Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol 2(5):17057. https:\/\/doi.org\/10.1038\/nmicrobiol.2017.57","journal-title":"Nat Microbiol"},{"issue":"6","key":"851_CR67","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1007\/s12602-021-09789-1","volume":"13","author":"LM Lazarenko","year":"2021","unstructured":"Lazarenko LM et al (2021) Assessment of the safety of Lactobacillus casei IMV B-7280 probiotic strain on a mouse model. Probiotics Antimicrob Proteins 13(6):1644\u20131657. https:\/\/doi.org\/10.1007\/s12602-021-09789-1","journal-title":"Probiotics Antimicrob Proteins"},{"key":"851_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57024-y","author":"Y Nami","year":"2024","unstructured":"Nami Y et al (2024) Anti-oral cancer properties of potential probiotic lactobacilli isolated from traditional milk, cheese, and yogurt. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-024-57024-y","journal-title":"Sci Rep"},{"key":"851_CR69","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1799667","author":"Y Peng","year":"2021","unstructured":"Peng Y, Yin S, Wang M (2021) Extracellular vesicles of bacteria as potential targets for immune interventions. Hum Vaccin Immunother. https:\/\/doi.org\/10.1080\/21645515.2020.1799667","journal-title":"Hum Vaccin Immunother"},{"key":"851_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115767","author":"Y Li","year":"2023","unstructured":"Li Y et al (2023) The functions and applications of extracellular vesicles derived from Mycobacterium tuberculosis. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2023.115767","journal-title":"Biomed Pharmacother"},{"key":"851_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxae249","author":"CM Bland","year":"2024","unstructured":"Bland CM, Love BL, Jones BM (2024) Human microbiome: impact of newly approved treatments on C. difficile infection. Am J Health Syst Pharm. https:\/\/doi.org\/10.1093\/ajhp\/zxae249","journal-title":"Am J Health Syst Pharm"},{"issue":"no. 11","key":"851_CR72","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s12275-021-1332-0","volume":"59","author":"Y Lee","year":"2021","unstructured":"Lee Y et al (2021) Activity of Lactobacillus crispatus isolated from vaginal microbiota against Mycobacterium tuberculosis. J Microbiol 59(11):1019\u20131030. https:\/\/doi.org\/10.1007\/s12275-021-1332-0","journal-title":"J Microbiol"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-025-00851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-025-00851-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-025-00851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:23:08Z","timestamp":1772605388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-025-00851-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1007\/s00430-025-00851-1","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: due to the funding information section was not published in the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in Animal Biosafety Level 3 (ABL-3) and Level 2 (ABL-2) laboratories at Soonchunhyang University. (SCH ABL-3 facility approval number: KDCA-20-3-04; ABL-2 facility approval number: LML20-591). All protocols and procedures were approved by the Institutional Animal Care and Use Committee (IACUC) and the Institutional Biosafety Committee (IBC) of Soonchunhyang University (SCH) and the HMMRC Center (IACUC approval numbers: SCH22-0042, SCH21-0049; IBC approval number: SCH22-002).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"43"}}